382 related articles for article (PubMed ID: 31546257)
1. High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Zauber AG; Knudsen AB; Ladabaum U
Ann Intern Med; 2019 Nov; 171(9):612-622. PubMed ID: 31546257
[TBL] [Abstract][Full Text] [Related]
2. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study.
Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Little M; Gray A; Duffy SW; Wooldrage K
Health Technol Assess; 2022 May; 26(26):1-156. PubMed ID: 35635015
[TBL] [Abstract][Full Text] [Related]
3. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
[TBL] [Abstract][Full Text] [Related]
4. Rescreening of persons with a negative colonoscopy result: results from a microsimulation model.
Knudsen AB; Hur C; Gazelle GS; Schrag D; McFarland EG; Kuntz KM
Ann Intern Med; 2012 Nov; 157(9):611-20. PubMed ID: 23128861
[TBL] [Abstract][Full Text] [Related]
5. Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study.
Atkin W; Cross AJ; Kralj-Hans I; MacRae E; Piggott C; Pearson S; Wooldrage K; Brown J; Lucas F; Prendergast A; Marchevsky N; Patel B; Pack K; Howe R; Skrobanski H; Kerrison R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran S
Health Technol Assess; 2019 Jan; 23(1):1-84. PubMed ID: 30618357
[TBL] [Abstract][Full Text] [Related]
6. The impact on clinical outcomes and healthcare resources from discontinuing colonoscopy surveillance subsequent to low-risk adenoma removal: A simulation study using the OncoSim-Colorectal model.
Steer KJ; Sun Z; Sadowski DC; Yong JHE; Coldman A; Nemecek N; Yang H
J Med Screen; 2024 Jun; 31(2):78-84. PubMed ID: 37728194
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
8. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
9. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
[TBL] [Abstract][Full Text] [Related]
10. Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model.
Meester RG; Doubeni CA; Lansdorp-Vogelaar I; Jensen CD; van der Meulen MP; Levin TR; Quinn VP; Schottinger JE; Zauber AG; Corley DA; van Ballegooijen M
JAMA; 2015 Jun; 313(23):2349-58. PubMed ID: 26080339
[TBL] [Abstract][Full Text] [Related]
11. Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study.
Cross AJ; Wooldrage K; Robbins EC; Kralj-Hans I; MacRae E; Piggott C; Stenson I; Prendergast A; Patel B; Pack K; Howe R; Swart N; Snowball J; Duffy SW; Morris S; von Wagner C; Halloran SP; Atkin WS
Gut; 2019 Sep; 68(9):1642-1652. PubMed ID: 30538097
[TBL] [Abstract][Full Text] [Related]
12. The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations.
Atkin W; Brenner A; Martin J; Wooldrage K; Shah U; Lucas F; Greliak P; Pack K; Kralj-Hans I; Thomson A; Perera S; Wood J; Miles A; Wardle J; Kearns B; Tappenden P; Myles J; Veitch A; Duffy SW
Health Technol Assess; 2017 Apr; 21(25):1-536. PubMed ID: 28621643
[TBL] [Abstract][Full Text] [Related]
13. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis.
van Hees F; Habbema JD; Meester RG; Lansdorp-Vogelaar I; van Ballegooijen M; Zauber AG
Ann Intern Med; 2014 Jun; 160(11):750-9. PubMed ID: 24887616
[TBL] [Abstract][Full Text] [Related]
14. Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.
Dinh TA; Alperin P; Walter LC; Smith R
J Gen Intern Med; 2012 Jun; 27(6):730-8. PubMed ID: 22237663
[TBL] [Abstract][Full Text] [Related]
15. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People.
Redwood DG; Dinh TA; Kisiel JB; Borah BJ; Moriarty JP; Provost EM; Sacco FD; Tiesinga JJ; Ahlquist DA
Mayo Clin Proc; 2021 May; 96(5):1203-1217. PubMed ID: 33840520
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of screening strategies for colorectal cancer.
Barzi A; Lenz HJ; Quinn DI; Sadeghi S
Cancer; 2017 May; 123(9):1516-1527. PubMed ID: 28117881
[TBL] [Abstract][Full Text] [Related]
19. Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness.
van Hees F; Saini SD; Lansdorp-Vogelaar I; Vijan S; Meester RG; de Koning HJ; Zauber AG; van Ballegooijen M
Gastroenterology; 2015 Nov; 149(6):1425-37. PubMed ID: 26253304
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
Lansdorp-Vogelaar I; Goede SL; Bosch LJW; Melotte V; Carvalho B; van Engeland M; Meijer GA; de Koning HJ; van Ballegooijen M
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):504-512.e11. PubMed ID: 28733262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]